Diagnostic Testing Procedures in Neurophysiology V1.0

Similar documents
Diagnostic Testing Procedures for Ophthalmic Science

Diagnostic Testing Procedures in Urodynamics V3.0

Diagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging

Tissue Viability Referral Pathway. April 2017

A list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.

Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline

School Vision Screening Policy V2.0

CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline

1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays.

Policy on Governance Arrangements Relating to Medicines V2.0

Loading Dose Worksheet for Oral Amiodarone

Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline

Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0

CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start

CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline

Newborn Hearing Screening Programme Policy

CLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline

CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE

CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS)

CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS

2.1. Applicable areas: Royal Cornwall Hospitals Trust; Neonatal Unit and Delivery Suite

2.1. It is essential that promoting and safeguarding the welfare of children and young people is integral to all NHS Trust policies and procedures.

PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

WARD CLOSURE POLICY V

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.

Safe Bathing Policy V1.3

CLINICAL GUIDELINE FOR: Management of low-risk upper GI haemorrhage. Page 1 of 10. Management of low-risk upper GI haemorrhage

CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0

IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

The initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0

CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline

Safeguarding Children Supervision Policy V4.0. November 2016

This guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.

ESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline

Procedure for the Application of a Cast and its subsequent care V1.3

OXYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0

Patient Experience Strategy

Occupational Health Surveillance Policy V2.1

Did Not Attend (DNA) and Cancellation Policy and Operational Guidelines

RCHT Non-Ionising Radiation Safety Policy

Health and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0

NORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY

Provision of Wigs Policy

MANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline

Safe Staffing Levels for. Midwifery, Nursing and Support Staff. For Maternity Service - Approved. Document V1.5. June 2017

Severe Weather Plan V5.5 March 2018

Other (please specify): Note: This policy has been assessed for any equality, diversity or human rights implications

CLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND

Central Alerting System (CAS) Policy

Management of Diagnostic Testing and Screening Procedures Policy

PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0

Version Number Date Issued Review Date V1: 28/02/ /08/2014

Animals and Pets in Healthcare Facilities Policy

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST. PATIENT ACCESS MANAGEMENT POLICY (Previously known as Waiting List Management Policy) Documentation Control

Date ratified November Review Date November This Policy supersedes the following document which must now be destroyed:

Moving and Handling Policy

Author: Kelvin Grabham, Associate Director of Performance & Information

POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007:

Healthcare consumer, Hospital and community based healthcare workers

REFERRAL TO TREATMENT ACCESS POLICY

DATA PROTECTION ACT (1998) SUBJECT ACCESS REQUEST PROCEDURE

Executive Director of Nursing and Chief Operating Officer

Document Title: Recruiting Process. Document Number: 011

Consultant to Consultant Referral Policy

GCP Training for Research Staff. Document Number: 005

Access to Health Records Procedure

This procedural document supersedes the previous procedural documents for Policy for the Management of Patients/Clients Access to Services

Implementation of the right to access services within maximum waiting times

DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY

Policy Summary. Policy Title: Policy and Procedure for Clinical Coding

Understanding the 18 week elective pathway and referral process, your rights and responsibilities

Health and Safety Policy

Trust Policy Access Policy For Planned Care Services

Delegation to Band 3 and 4 Nursing Unregistered Support Workers Guidance for Staff and Managers. Version No.1 Review: November 2019

CCG CO21 Continuing Healthcare Policy on the Commissioning of Care

Lone worker policy. Director of Nursing Therapies Patient Partnership Author and contact number Safety and Security Lead

18 Weeks Referral to Treatment (RTT) Waiting times

NON-MEDICAL PRESCRIBING POLICY

RECEIPT & SCRUTINY OF MENTAL HEALTH ACT PAPERS

Learning from Deaths Policy LISTEN LEARN ACT TO IMPROVE

Hospital Generated Inter-Speciality Referral Policy Supporting people in Dorset to lead healthier lives

Document Title: Document Number:

Medical Devices Management Policy

Referral to Treatment (RTT) Access Policy

CEREBRAL FUNCTION MONITORING (aeeg). NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Other (please specify): Note: This document has been assessed for any equality, diversity or human rights implications

Legal Retention and Destruction of

Safeguarding Adults Policy

Learning from the Deaths of Patients in our Care Policy

Specialised Services: CPL-008 Referral Management Policy

MORTALITY REVIEW POLICY

Wandsworth CCG. Continuing Healthcare Commissioning Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Named Key Worker for Cancer Patients Policy

Section 19 Mental Health Act 1983 Regulations as to the transfer of patients

Hand Hygiene Policy V2.1

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines

Version: Date Adopted: 20 October Name of responsible Committee: Date issue for publication: Review Date: March 2018

Birmingham, Sandwell and Solihull Eligibility Criteria Policy for NHS Non-Emergency Patient Transport (NEPT)

Transcription:

V1.0 10 September 2012

Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the Managers... 3 5.3. Role of the Medicine & ED Divisional Governance Management Board... 4 5.5. Role of Individual Staff... 4 5.10. Role of Governance Leads... 4 6. Standards and Practice... 4 6.1. Diagnostic tests provided by the service... 4 6.3. Risk assessment of diagnostic tests... 4 6.7. Requesting diagnostic tests... 5 6.9. Patient preparation... 5 6.11. Informed consent... 5 6.16. How the diagnostic test is requested... 5 6.29. How the patient is informed of test results... 6 6.33. Actions to be taken by a person receiving test results... 6 6.39. How the minimum requirements are recorded... 7 6.54. How the organisation monitors compliance... 8 7. Dissemination and Implementation... 8 8. Monitoring compliance and effectiveness... 8 9. Updating and Review... 8 10. Equality and Diversity... 8 10.2. Equality Impact Assessment... 8 Appendix 1. Diagnostic tests undertaken by the Neurophysiology Department... 9 Appendix 2. Governance Information... 10 Appendix 3.Initial Equality Impact Assessment Screening Form... 12 Page 2 of 13

1. Introduction 1.1. This policy describes the testing procedures undertaken by the Department of Neurophysiology and sets out the procedures governing their procurement, performance and reporting. 1.2. This version supersedes any previous versions of this document. 2. Purpose of this Policy/Procedure 2.1. The purpose of this policy is to prevent avoidable harm to patients who need neurophysiology tests, arising 2.1.1. directly from the tests performed, or 2.1.2. from delays in tests being undertaken, or 2.1.3. from delays in reporting the results of tests, or 2.1.4. from delays in acting upon the results. 3. Scope 3.1. This policy applies to all those who request neurophysiology diagnostic tests, those who perform them and those who receive, process or need to act on the results. 4. Definitions / Glossary GP: General Practitioner PAS: Patient Administration System RCHT: Royal Cornwall Hospitals NHS Trust 5. Ownership and Responsibilities 5.1. The strategic and operational roles responsible for the development, management and implementation of the policy are shown below. 5.2. Role of the Managers Line managers are responsible for: conducting stringent recruitment checks to ensure that only appropriately qualified and registered staff undertake tests and authorise test results; checking professional registration in line with renewal requirements; checking staff training and competence to perform tests; ensuring that staff follow established processes and procedures, as described below. Page 3 of 13

5.3. Role of the Medicine & ED Divisional Governance Management Board 5.4. The Medicine & ED Divisional Governance Management Board is responsible for the development, approval and communication of this policy and monitoring compliance with it. 5.5. Role of Individual Staff 5.6. The diagnostic pathway begins when a request is generated; it progresses via the diagnostic testing process and ends when a report is received by the requestor and acted upon. Various healthcare staff are involved in this pathway including Doctors, Nurses, Healthcare Assistants/Support workers and Professions Allied to Medicine. 5.7. Ward based administrative staff have an important role in ensuring that, for paper based reporting systems, all results are communicated to the clinical staff in charge of the patient. 5.8. Neurophysiology Department staff must ensure that any paper reports are despatched in a timely manner. 5.9. All staff members are responsible for: being aware of this policy and any documents referred to within it pertaining to their part in the diagnostic pathway. adhering to any requirements described within this policy and documents described in the standards and practice section pertaining to their role in the diagnostic pathway. 5.10. Role of Governance Leads 5.11. It is the responsibility of Governance Leads to ensure that processes are in place within specialties which ensure that every neurophysiology test result is acted upon. 6. Standards and Practice 6.1. Diagnostic tests provided by the service 6.2. A list of tests provided by the Neurophysiology Service may be found at Appendix 1. 6.3. Risk assessment of diagnostic tests 6.4. Diagnostic tests are evaluated prior to introduction (e.g. to check that they are fit for purpose, that they are within the competence of the staff who will perform them, etc.). 6.5. As new guidelines are developed or equipment introduced, the level of risk is reassessed. 6.6. Responsibility for ensuring that these tasks are undertaken by suitably qualified personnel rests with the Specialty Lead for Neurophysiology at the time. Page 4 of 13

6.7. Requesting diagnostic tests 6.8. Test requests are made for both inpatients and outpatients and fall into 3 categories: those ordered by Trust clinicians; those ordered directly by General Practitioners to inform their decisions in primary care; those ordered by clinicians working for other healthcare providers. 6.9. Patient preparation 6.10. Where any specific measure is required (e.g. fasting, cessation of medication), it will be indicated in user guides/requesting information or specific information provided for patients. 6.11. Informed consent 6.12. Patient consent is required for all neurophysiology testing procedures but it need only be oral consent. 6.13. In all cases, the person obtaining consent must be satisfied that the patient is giving informed consent, i.e. that the patient has been given and understood all relevant information about the proposed procedure. 6.14. Informed consent for a diagnostic test must either be obtained or checked by the person performing the test. 6.15. Further information may be found in the RCHT consent policy. 6.16. How the diagnostic test is requested 6.17. Format 6.18. Tests may be requested by completion of a pre-printed form or by letter. 6.19. In the case of letters dictated following attendances at outpatient clinics, it is recognised that avoidance of delay is contingent upon prompt transcription. Until order communication for neurophysiology is in place, referring clinicians are responsible for taking all necessary steps to ensure that urgent requests are placed without delay. 6.20. Process 6.21. Referrals may be sent to the Neurophysiology Department by post, fax or e- mail. A daily check of all sources is made from Monday to Friday and paper copies of all referrals are date stamped. 6.22. Referrals are sorted by test category and the number of referrals recorded on a monthly basis. 6.23. For straightforward tests, outpatient appointments are sent or arrangements made with the wards if the patient is an inpatient. Page 5 of 13

6.24. Some referrals are measured against set criteria, following which they are either returned to referrers or appointed as for straightforward tests. 6.25. Some referrals are passed to a consultant neurologist for expert vetting. In these cases, a record is made of the onward referral and subsequent return to ensure that no referral is lost in the process. 6.26. How the person requesting the test is informed of test results 6.27. All reports are sent to referring clinicians to their offices or the wards where their patients are located - in paper format. A documentary record of the sending of every result is kept in the department. 6.28. Copies of all reports are kept with their respective referral letters in the Neurophysiology Department or filed (or sent for filing) in the patient casenotes. 6.29. How the patient is informed of test results 6.30. Patients must be made aware of the reason for tests being requested and the approximate timescale and communication method for availability of the results so that they may request an update on results as necessary. Results which have significant implications for the patient must be discussed with them in the appropriate timescale. 6.31. There is an expectation that patients are informed of results by the requesting clinician in a timely fashion. It is the responsibility of the requestor to consider how, when and what to tell the patient. 6.32. The mechanisms and timescales for informing patients of results are the responsibility of the requesting clinician but may include, according to the nature of the test, availability of result and the significance of the result: telling patients (face to face or, with the consent of the patient, by telephone); writing to patients; discussing with patients at outpatient or pre-operative assessment clinics; writing to the patient s GP; adding to a discharge summary letter. 6.33. Actions to be taken by a person receiving test results 6.34. The person receiving the results should ensure the results are brought to the attention (urgently if necessary) of the clinical team currently caring for the patient. Results should be reviewed by a person with clinical responsibility for the patient who is able to interpret the results and ensure a management plan is recorded as required. 6.35. A requesting consultant will take responsibility for ALL investigations requested personally or in her/his name, but responsibility for signing off a result can be appropriately delegated. Page 6 of 13

6.36. Requesting clinicians are responsible for reviewing urgent results requested during their shift, and passing the responsibility on if they finish their shift. For those tests that are requested but the patient has moved on to another area when the test is done or the result is available, responsibility for the results passes to the clinician responsible for the patient in that area. 6.37. It is incumbent on the responsible clinician to ensure that he or she personally checks the reporting systems on a regular basis for the investigation results and then acts on the information within the report with the necessary degree of urgency. If they are unable to do this they must hand the responsibility over to a colleague. Failure to do this may put patients at risk. 6.38. Safety net procedures must be established by requestors, to ensure high risk diagnoses and results are not inadvertently missed. The procedure must take account of patients moving from area to area within a hospital and being discharged before results are received. 6.39. How the minimum requirements are recorded 6.40. Requesting 6.41. Requests received by Neurophysiology are recorded on receipt by batch totals on the departmental whiteboard. 6.42. Outpatient tests are recorded as outpatient appointments on the PAS system and on the local database. 6.43. Inpatient tests are recorded on the local database. 6.44. Informing the clinician 6.45. A documentary record of the sending of every result is kept in the department. 6.46. Communication of test results between clinical staff who have received results and other healthcare staff or patients must be recorded in the notes. 6.47. Informing the patient 6.48. Records are kept of any discussion or correspondence with patients or their GP in the casenotes. 6.49. Actions taken 6.50. Actions taken are documented in the casenotes. 6.51. When recording results within the patient s casenotes, the minimum information which must be included is: forename and surname NHS/Hospital number for unknown patients a coded identifier may be used test or procedure date and time test was performed Interpretive comments made or conclusion reached may also be recorded. 6.52. The method of communication of the actions must be recorded, i.e. face to face contact, phone call, letter, email, fax, etc. Page 7 of 13

6.53. Hospital discharge summaries should record confirmed diagnosis and any outstanding investigations. 6.54. How the organisation monitors compliance 6.55. The lack of an integrated neurophysiology information system is not compatible with effective, sustainable compliance monitoring. It is acknowledged that consideration must be given to the development of suitable technologies and processes to address this requirement. 7. Dissemination and Implementation 7.1. This document will be placed on the Cornwall & Isles of Scilly Health Community Documents Library with notification to all users via email. 8. Monitoring compliance and effectiveness Element to be monitored Lead Patients progressing through RTT pathways Service Lead Tool Booking Tool to be used to monitor diagnostic and Phase 2 patients Frequency Reporting arrangements Acting on recommendations and Lead(s) Change in practice and lessons to be shared Booking Tool is reviewed on a weekly basis to ensure diagnostics booked within required booking window and Phase 2 patients are monitored on a weekly basis to ensure pathways progressing Reported through local Performance Meeting and RTT Meeting RTT Committee Through local Performance Meeting and Neurology Specialty/Governance Meeting 9. Updating and Review 9.1. This policy will be reviewed every two years or sooner if circumstances suggest this may be necessary. 10. Equality and Diversity 10.1. This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement. 10.2. Equality Impact Assessment 10.3. The Initial Equality Impact Assessment Screening Form is at Appendix 3. Page 8 of 13

Appendix 1. Diagnostic tests undertaken by the Neurophysiology Department TEST TYPE OF CONSENT Electroencephalography (EEG) - departmental Oral - ambulatory Oral Evoked Potentials (EP) Electromyography (EMG) Nerve Conduction Velocity Studies (NCV) Adult and Paediatric Video Telemetry Oral Oral Oral Oral Page 9 of 13

Appendix 2. Governance Information Document Title Diagnostic Testing Procedures in Neurophysiology Date Issued/Approved: 18 September 2012 Date Valid From: 18 September 2012 Date Valid To: 18 September 2015 Directorate / Department responsible (author/owner): Helen Williams, Service Lead, General Surgery Contact details: 01872 252218 Brief summary of contents Suggested Keywords: Target Audience Executive Director responsible for Policy: Date revised: This document replaces (exact title of previous version): Approval route (names of committees)/consultation: This policy sets out an approved documented process whereby the risks associated with diagnostic testing procedures in Neurophysiology are managed. Diagnostic results, diagnostic reporting, management of results RCHT PCT CFT Medical Director New Document New Document Specialty Lead Divisional Manager confirming approval processes Name and Post Title of additional signatories Signature of Executive Director giving approval Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder Links to key external standards Related Documents: Rowena Green Dr Brendan McLean, Consultant Neurologist & Specialty Lead {Original Copy Signed} Internet & Intranet Intranet Only Clinical / Neurology and Stroke NHSLA Standard 5 Criterion 7: Diagnostic Testing Procedures Safer Practice Notice 16, February 2007 An Organisation-wide Policy for the Page 10 of 13

Training Need Identified? Management of Diagnostic Testing Procedures No Version Control Table Date 10 Sept 2012 Version No V1.0 Initial Issue Summary of Changes Changes Made by (Name and Job Title) Helen Williams, Service Lead, Medicine All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of expiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the express permission of the author or their Line Manager. Page 11 of 13

Appendix 3.Initial Equality Impact Assessment Screening Form Name of service, strategy, policy or project (hereafter referred to as policy) to be assessed: Diagnostic Testing Procedures Directorate and service area: Medicine & Is this a new or existing Procedure? New ED, Neurology & Neurophysiology Name of individual completing Telephone: 01872 252218 assessment: Helen Williams, Service Lead 1. Policy Aim* Sets out an approved documented process whereby the risks associated with diagnostic testing procedures are managed through the provision of local policies which are implemented and monitored. 2. Policy Objectives* The risks associated with diagnostic testing procedures are minimised; compliance with Diagnostic Testing Procedures is achieved. 3. Policy intended To ensure that the diagnostic process contributes the Outcomes* maximum benefit to the treatment of patients. 4. How will you measure the outcome? 5. Who is intended to benefit from the Policy? 6a. Is consultation required with the workforce, equality groups, local interest groups etc. around this policy? As described in Section in the Monitoring Compliance section of this policy. All patients. No. b. If yes, have these groups been consulted? c. Please list any groups who have been consulted about this procedure. *Please see Glossary 7. The Impact Please complete the following table using ticks. You should refer to the EA guidance notes for areas of possible impact and also the Glossary if needed. Where you think that the policy could have a positive impact on any of the equality group(s) like promoting equality and equal opportunities or improving relations within equality groups, tick the Positive impact box. Page 12 of 13

Where you think that the policy could have a negative impact on any of the equality group(s) i.e. it could disadvantage them, tick the Negative impact box. Where you think that the policy has no impact on any of the equality group(s) listed below i.e. it has no effect currently on equality groups, tick the No impact box. Equality Group Age Positive Impact Negative Impact No Impact Reasons for decision Disability Religion or belief Gender Transgender Pregnancy/ Maternity Race Sexual Orientation Marriage / Civil Partnership You will need to continue to a full Equality Impact Assessment if the following have been highlighted: A negative impact and No consultation (this excludes any policies which have been identified as not requiring consultation). 8. If there is no evidence that the policy promotes equality, equal opportunities or improved relations - could it be adapted so that it does? How? Full statement of commitment to policy of equal opportunities is included in the policy Please sign and date this form. Keep one copy and send a copy to Matron, Equality, Diversity and Human Rights, c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Chyvean House, Penventinnie Lane, Truro, Cornwall, TR1 3LJ A summary of the results will be published on the Trust s web site. Signed Date Page 13 of 13